Predicting PET amyloid positivity in the intermediate plasma p ‐tau217 group

AAIC 2025 Abstract

Abstract

Background: Plasma phosphorylated tau 217 ( p ‐tau217) has shown promise as a less invasive, fast, and cost‐efficient method to improve early detection of Alzheimer’s disease (AD).

The paper